Chemveda Life Sciences is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) based in Hyderabad, India. We are dedicated to enabling global pharmaceutical, biotechnology, agrochemical, cosmeceutical, academic, and other partners in the life science sector to achieve their R&D goals. With a skilled team of chemists and manufacturing professionals, we provide comprehensive services that help our partners achieve critical milestones faster, more efficiently, and cost-effectively.
Founded in 2008 by Dr. Bheema Rao Paraselli, Chemveda has grown into a powerhouse of over 600 employees with facilities and technology divisions. We have offices in San Diego and Boston in the United States.
Chemveda harnesses its scientific and technological expertise to deliver full-suite chemistry support, ranging from lab-scale synthesis to process R&D and large-scale custom development of drug substances, key intermediates, and starting materials across multiple chemistry classes.
We are committed to addressing the evolving challenges in both basic and applied research, investing in in-house expertise in sought-after scientific platforms. Our dedication to client satisfaction is reflected in our high retention rate, with over 40% of our clients returning for repeat collaborations in the past five years.
Guided by our visionary founder, Dr. Bheema Rao Paraselli, and a distinguished advisory board including leaders such as Prof. K.C. Nicolaou, Prof. Phil S. Baran, and Prof. Jin Quan Yu, we are proud of our robust leadership and the strategic guidance that drives our scientific and business direction.
At Chemveda, people are at the heart of everything we do. Our investment in cutting-edge infrastructure, processes, and equipment ensures that we stay ahead of
industry standards.
Our scientific team is mentored by some of the brightest minds in the industry, enabling us to offer solutions that push the boundaries of innovation. As a trusted CRO-CDMO partner, we prioritize the security of our clients’ intellectual property, fostering long-term, transparent, and mutually beneficial partnerships.
Our goal is not just to grow our scientific and human capabilities but to create enduring value for our clients, shareholders, and society.